Leadership Team

Wa’el Hashad joined Avanir Pharmaceuticals as President and Chief Executive Officer in July 2017. Wa’el is a passionate leader with more than 25 years of experience in biopharmaceutical management, sales and marketing, within both the U.S. and...

In June 2016 Dan Dalton was named Senior Vice President and Chief Compliance Officer of Avanir Pharmaceuticals. Dan came to Avanir with more than 25 years of experience working with biopharmaceutical and medical device companies. He brings...

Aneta Ferguson joined Avanir Pharmaceuticals in January 2015 and currently serves as Executive Director, General Counsel. Under her leadership, the Law Department is responsible for counseling Avanir on FDA regulatory matters, product life cycle...

Lisa Locklear joined Avanir Pharmaceuticals in September 2018 as Vice President and Chief Financial Officer. She brings extensive operational and strategic finance leadership to oversee the financial operations of Avanir, including controllership and...

Nori Maei was appointed Vice President of Business Planning and Alliance Management in March 2015. He is responsible for all aspects of the Otsuka/Avanir alliance and is also in charge of planning international aspects of the business. Nori brings...

Kelly Parker joined Avanir Pharmaceuticals in June 2015 and now leads the Human Resources and Corporate Communications functions. In this role Kelly provides leadership, strategic vision and functional expertise to her team and the company. Prior to...

Mike Tilton joined Avanir Pharmaceuticals as Chief Commercial Officer in August 2020 to lead Avanir’s commercial operations, including sales and revenue growth, product marketing and Avanir’s go-to-market strategies. Mike brings more than 30 years of...